US-based DermaSensor has announced a newly published study showing that its AI-powered device can improve a primary care physician's ability to assess moles of concern. In the prospective study, ...

The advanced development of medical technology has accelerated in recent years, with devices being continuously manufactured for healthcare professionals as well as consumers at home. From wellbeing ...

MIAMI--(BUSINESS WIRE)--DermaSensor Inc., a health technology company designing non-invasive tools to better equip primary care physicians for skin cancer detection, today announced the publication of ...

MIAMI--(BUSINESS WIRE)--DermaSensor Inc., a health technology company equipping primary care physicians (PCPs) with a non-invasive device for use in evaluation of suspicious skin lesions, presented to ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company's COO discussed its ...

Medtech company DermaSensor has claimed FDA approval for a handheld device, powered by artificial intelligence (AI), that can be used to detect skin cancer at the point of care. The eponymous device, ...

The FDA has cleared DermaSensor’s first-of-its-kind handheld device that uses artificial intelligence to non-invasively detect skin cancer, the Miami-based device maker announced Wednesday. Physicians ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Florida native leads a ...

DermaSensor, a health technology company transforming skin cancer detection with AI-powered technology, today announced it has received Class IIb CE Mark for the DermaSensor device, enabling ...

Follow this author to personalize your feed and get instant alerts. WHY FOLLOW? Custom Feed: See the stories that matter most to you. Smart Alerts: Get notified about major news as it happens. Update ...